JNJ — Johnson & Johnson Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Johnson & Johnson, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

	2022 January 2nd	2023 December 31st	2023 January 1st	2024 December 29th	2025 December 28th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	fx Preliminary
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31,608	22,927	23,519	24,522	—
Net Total Accounts Receivable
Net Total Receivables	15,283	14,873	16,160	14,842	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	60,979	53,495	55,294	55,893	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,862	20,898	20,903	21,618	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	182,018	167,558	187,378	180,104	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,226	46,282	55,802	50,321	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	107,995	98,784	110,574	108,614	—
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	74,023	68,774	76,804	71,490	—
Total Liabilities & Shareholders' Equity	182,018	167,558	187,378	180,104	—
Total Common Shares Outstanding